| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 35317099 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L ARHGAP32 CRTC3 ABI1 WWTR1 LPIN3 FAM171A1 ZNF106 DCP1B LMO7 STARD9 TBC1D1 RBM14 HELZ CTNND1 | 3.75e-07 | 861 | 122 | 15 | 36931259 |
| Pubmed | ATXN2L FAM193B ZSWIM8 ARHGAP32 ATN1 RBM10 NOXA1 PFKL RBM14 LRP2 RBM24 RAD23B | 1.66e-06 | 608 | 122 | 12 | 16713569 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TRERF1 ATXN2L MYBBP1A ATN1 RBM10 SEMA5A PNISR PCF11 ZNF106 LMO7 RBM14 HELZ SUZ12 | 3.52e-06 | 774 | 122 | 13 | 15302935 |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 3.59e-06 | 180 | 122 | 7 | 35198878 | |
| Pubmed | 4.96e-06 | 10 | 122 | 3 | 24785509 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ATXN2L FLNB ARHGAP32 ABI1 NEBL CEMIP2 CRKL CDKL5 LMO7 CTNND1 SNX9 | 5.22e-06 | 565 | 122 | 11 | 25468996 |
| Pubmed | 8.43e-06 | 205 | 122 | 7 | 20436479 | ||
| Pubmed | ATXN2L FLNB ARHGAP32 ABI1 PFKL CRKL CDKL5 DLGAP3 TENM4 GPR158 CNTNAP2 HELZ CTNND1 BSN NOS1 | 1.14e-05 | 1139 | 122 | 15 | 36417873 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 30371171 | ||
| Pubmed | [Expression of GATA3 and bcl-11b in peripheral T-cell lymphoma and their clinical significance]. | 1.22e-05 | 2 | 122 | 2 | 34344074 | |
| Pubmed | Regulation of corneal epithelial barrier function by Kruppel-like transcription factor 4. | 1.22e-05 | 2 | 122 | 2 | 21051695 | |
| Pubmed | Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. | 1.36e-05 | 86 | 122 | 5 | 10862698 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | FLNB ABI1 NEBL ADGRV1 PFKL PLD3 ECE1 CEMIP2 COL18A1 TPP1 LRP2 N4BP2L2 MYO15A SNX9 | 1.38e-05 | 1016 | 122 | 14 | 19056867 |
| Pubmed | 1.43e-05 | 407 | 122 | 9 | 12693553 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FLNB ASH1L ADGRV1 PFKL PLD3 PLBD2 SBNO2 HIPK3 ZNF462 COL18A1 PXDN GRTP1 GPR158 TBC1D1 NLRC5 CTNND1 SNX9 | 1.82e-05 | 1489 | 122 | 17 | 28611215 |
| Pubmed | ATN1 RHBDD2 PFKL ECE1 CEMIP2 SBNO2 LPIN3 TPP1 RBM14 CARD6 HELZ | 1.92e-05 | 650 | 122 | 11 | 38777146 | |
| Pubmed | 1.93e-05 | 233 | 122 | 7 | 37704626 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.21e-05 | 430 | 122 | 9 | 35044719 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ARHGAP32 ABI1 GJC1 DCBLD1 CEMIP2 CDKL5 MROH6 GPR158 PCDH11X CTNND1 | 3.40e-05 | 569 | 122 | 10 | 30639242 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 3.55e-05 | 457 | 122 | 9 | 32344865 | |
| Pubmed | Bcl11b, a novel GATA3-interacting protein, suppresses Th1 while limiting Th2 cell differentiation. | 3.65e-05 | 3 | 122 | 2 | 29514917 | |
| Pubmed | Krüppel-like Factor 4 activates HBG gene expression in primary erythroid cells. | 3.65e-05 | 3 | 122 | 2 | 21539536 | |
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 29025973 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 32193376 | ||
| Pubmed | The association of semaphorins 3C, 5A and 6D with liver fibrosis stage in chronic hepatitis C. | 3.65e-05 | 3 | 122 | 2 | 30592759 | |
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 23209159 | ||
| Pubmed | ATXN2L FLNB ARHGAP32 MYBBP1A ABI1 PFKL PLD3 CDKL5 DLGAP3 TENM4 LRIG1 LMO7 RBM14 CTNND1 BSN NOS1 | 4.20e-05 | 1431 | 122 | 16 | 37142655 | |
| Pubmed | 5.40e-05 | 274 | 122 | 7 | 34244482 | ||
| Pubmed | EG-1 interacts with c-Src and activates its signaling pathway. | 6.18e-05 | 22 | 122 | 3 | 16964398 | |
| Pubmed | Loss of LKLF function results in embryonic lethality in mice. | 7.29e-05 | 4 | 122 | 2 | 9859212 | |
| Pubmed | Asynchronous combinatorial action of four regulatory factors activates Bcl11b for T cell commitment. | 7.29e-05 | 4 | 122 | 2 | 27376470 | |
| Pubmed | 7.29e-05 | 4 | 122 | 2 | 19961619 | ||
| Pubmed | 7.29e-05 | 4 | 122 | 2 | 23023329 | ||
| Pubmed | 7.29e-05 | 4 | 122 | 2 | 16507336 | ||
| Pubmed | The secreted protease Adamts18 links hormone action to activation of the mammary stem cell niche. | 7.29e-05 | 4 | 122 | 2 | 32218432 | |
| Pubmed | 7.42e-05 | 503 | 122 | 9 | 16964243 | ||
| Pubmed | 9.15e-05 | 25 | 122 | 3 | 19092943 | ||
| Pubmed | 9.15e-05 | 25 | 122 | 3 | 21536733 | ||
| Pubmed | TRERF1 ATXN2L CRTC3 MYBBP1A GATA3 PFKL CRKL RBM14 HELZ CTNND1 | 1.09e-04 | 655 | 122 | 10 | 35819319 | |
| Pubmed | 1.48e-04 | 225 | 122 | 6 | 12168954 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 1.49e-04 | 552 | 122 | 9 | 10737800 | |
| Pubmed | TRERF1 ARHGAP32 MYBBP1A ABI1 ZNF462 FAM171A1 DLGAP3 BCL11B GPR158 CTNND1 BSN NOS1 | 1.51e-04 | 963 | 122 | 12 | 28671696 | |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 1.62e-04 | 327 | 122 | 7 | 15592455 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.66e-04 | 560 | 122 | 9 | 21653829 | |
| Pubmed | HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages. | 1.94e-04 | 32 | 122 | 3 | 27114546 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ATXN2L FLNB MYBBP1A ABI1 RBM10 MCM6 NHLRC2 PFKL LMO7 TPP1 RBM14 SNX9 RAD23B | 2.06e-04 | 1149 | 122 | 13 | 35446349 |
| Pubmed | 2.11e-04 | 153 | 122 | 5 | 10718198 | ||
| Pubmed | Mammalian Krüppel-like transcription factors: more than just a pretty finger. | 2.53e-04 | 7 | 122 | 2 | 10366853 | |
| Pubmed | 2.53e-04 | 7 | 122 | 2 | 23359715 | ||
| Pubmed | Endothelial Cyp26b1 restrains murine heart valve growth during development. | 2.83e-04 | 163 | 122 | 5 | 35364055 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 2.97e-04 | 256 | 122 | 6 | 33397691 | |
| Pubmed | 3.00e-04 | 37 | 122 | 3 | 29044125 | ||
| Pubmed | 3.23e-04 | 613 | 122 | 9 | 22268729 | ||
| Pubmed | ATXN2L MYBBP1A AVL9 RPS6KA3 PLD3 PCF11 COL18A1 LMO7 STARD9 RBM14 MPLKIP CPNE1 CTNND1 RAD23B | 3.31e-04 | 1371 | 122 | 14 | 36244648 | |
| Pubmed | 3.37e-04 | 8 | 122 | 2 | 32259481 | ||
| Pubmed | 3.37e-04 | 8 | 122 | 2 | 18586225 | ||
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 3.37e-04 | 8 | 122 | 2 | 23130995 | |
| Pubmed | 3.37e-04 | 8 | 122 | 2 | 38760361 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | TRERF1 ASH1L GATA3 KLF4 HOXA6 OTP BCL11B NKX6-3 HOXD8 KLF1 ZNF396 | 3.65e-04 | 908 | 122 | 11 | 19274049 |
| Pubmed | 4.32e-04 | 9 | 122 | 2 | 15696170 | ||
| Pubmed | Ulk4, a Newly Discovered Susceptibility Gene for Schizophrenia, Regulates Corticogenesis in Mice. | 4.32e-04 | 9 | 122 | 2 | 34235142 | |
| Pubmed | 4.32e-04 | 9 | 122 | 2 | 28224988 | ||
| Pubmed | 4.32e-04 | 9 | 122 | 2 | 20956546 | ||
| Pubmed | 4.36e-04 | 100 | 122 | 4 | 10048485 | ||
| Pubmed | 5.37e-04 | 399 | 122 | 7 | 35987950 | ||
| Pubmed | Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. | 5.39e-04 | 10 | 122 | 2 | 21263130 | |
| Pubmed | The erythroid phenotype of EKLF-null mice: defects in hemoglobin metabolism and membrane stability. | 5.39e-04 | 10 | 122 | 2 | 15923635 | |
| Pubmed | 5.39e-04 | 10 | 122 | 2 | 24124161 | ||
| Pubmed | Development and differentiation of early innate lymphoid progenitors. | 5.39e-04 | 10 | 122 | 2 | 29183988 | |
| Pubmed | 5.39e-04 | 10 | 122 | 2 | 34145365 | ||
| Pubmed | 5.69e-04 | 403 | 122 | 7 | 35253629 | ||
| Pubmed | 5.76e-04 | 529 | 122 | 8 | 14621295 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 5.81e-04 | 665 | 122 | 9 | 30457570 | |
| Pubmed | 6.10e-04 | 47 | 122 | 3 | 35462405 | ||
| Pubmed | SUMF2 CRTC3 MAK MYOZ3 PLD3 ECE1 SBNO2 TPP1 UGT2A3 HELZ CTNND1 RBM24 ANO3 | 6.30e-04 | 1293 | 122 | 13 | 15342556 | |
| Pubmed | EED and KDM6B coordinate the first mammalian cell lineage commitment to ensure embryo implantation. | 6.57e-04 | 11 | 122 | 2 | 23671187 | |
| Pubmed | Abnormal activation of Yap/Taz contributes to the pathogenesis of tuberous sclerosis complex. | 6.57e-04 | 11 | 122 | 2 | 34999833 | |
| Pubmed | Active intermixing of indirect and direct neurons builds the striatal mosaic. | 6.57e-04 | 11 | 122 | 2 | 30413696 | |
| Pubmed | 6.57e-04 | 11 | 122 | 2 | 23487314 | ||
| Pubmed | 7.32e-04 | 549 | 122 | 8 | 38280479 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CRTC3 MYBBP1A MAK ABI1 RHBDD2 MCM6 LPIN3 DCP1B LMO7 TBC1D1 RBM14 HELZ SNX9 | 7.67e-04 | 1321 | 122 | 13 | 27173435 |
| Pubmed | 7.86e-04 | 204 | 122 | 5 | 25659154 | ||
| Pubmed | ABI1 GALNT3 NEBL RHBDD2 PFKL KLF4 PNISR PCF11 COL18A1 PXDN TPP1 HELZ SUZ12 RAD23B | 7.87e-04 | 1497 | 122 | 14 | 31527615 | |
| Pubmed | 7.87e-04 | 117 | 122 | 4 | 17145500 | ||
| Pubmed | 7.87e-04 | 12 | 122 | 2 | 15937668 | ||
| Pubmed | Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican. | 7.87e-04 | 12 | 122 | 2 | 32648916 | |
| Pubmed | Molecular mechanisms underlying inner ear patterning defects in kreisler mutants. | 7.87e-04 | 12 | 122 | 2 | 16325169 | |
| Pubmed | A global role for KLF1 in erythropoiesis revealed by ChIP-seq in primary erythroid cells. | 7.87e-04 | 12 | 122 | 2 | 20508144 | |
| Pubmed | 7.87e-04 | 12 | 122 | 2 | 12446789 | ||
| Pubmed | Comprehensive transcriptome analysis of cochlear spiral ganglion neurons at multiple ages. | 7.87e-04 | 12 | 122 | 2 | 31913118 | |
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 7.87e-04 | 12 | 122 | 2 | 25770910 | |
| Pubmed | 8.21e-04 | 52 | 122 | 3 | 26633812 | ||
| Pubmed | ATXN2L FLNB MYBBP1A RBM10 PCF11 ZNF462 LMO7 RBM14 CTNND1 RAD23B | 8.26e-04 | 847 | 122 | 10 | 35850772 | |
| Pubmed | 8.32e-04 | 430 | 122 | 7 | 32581705 | ||
| Pubmed | 9.13e-04 | 709 | 122 | 9 | 22988430 | ||
| Pubmed | 9.28e-04 | 13 | 122 | 2 | 33510165 | ||
| Pubmed | 9.28e-04 | 13 | 122 | 2 | 39250533 | ||
| Pubmed | 9.28e-04 | 13 | 122 | 2 | 36793543 | ||
| Pubmed | 9.28e-04 | 13 | 122 | 2 | 23622063 | ||
| Interaction | GRIN1 interactions | 3.95e-06 | 154 | 120 | 8 | int:GRIN1 | |
| Interaction | GRIN2B interactions | 8.19e-06 | 170 | 120 | 8 | int:GRIN2B | |
| Cytoband | 2q24-q31 | 2.10e-05 | 3 | 122 | 2 | 2q24-q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 5.08e-04 | 137 | 122 | 4 | chr9q31 | |
| Cytoband | 18q12 | 5.36e-04 | 13 | 122 | 2 | 18q12 | |
| Cytoband | 9q31.2 | 8.20e-04 | 16 | 122 | 2 | 9q31.2 | |
| GeneFamily | Zinc fingers C2H2-type|Kruppel like factors | 2.49e-03 | 18 | 75 | 2 | 624 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.77e-03 | 19 | 75 | 2 | 50 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.82e-03 | 718 | 75 | 9 | 28 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 3.07e-03 | 20 | 75 | 2 | 736 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE | 3.57e-06 | 195 | 121 | 8 | M45684 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN | 3.99e-06 | 198 | 121 | 8 | M4603 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FLNB ABI1 AVL9 RPS6KA3 SEMA5A WWTR1 PNISR PCF11 FAM171A1 LRIG1 LHFPL2 HELZ N4BP2L2 SUZ12 RAD23B | 9.80e-06 | 856 | 121 | 15 | M4500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | MGAM ASH1L NHLRC2 PFKL KMT2E PNISR CEMIP2 ZNF462 PCDH11X ADAMTS18 LHFPL2 RAD23B | 4.02e-06 | 417 | 119 | 12 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | ASAH2 DCBLD1 SEMA5A WWTR1 PLXND1 ECE1 KLF4 CEMIP2 FAM171A1 PXDN LHFPL2 CTNND1 | 9.91e-06 | 456 | 119 | 12 | GSM777032_500 |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | DCBLD1 SEMA5A WWTR1 PLXND1 ECE1 KLF4 CEMIP2 PXDN SEMA6D HOXD8 LHFPL2 CTNND1 | 1.06e-05 | 459 | 119 | 12 | GSM777037_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | MGAM ASH1L SEMA5A PFKL KMT2E PNISR TENM4 STARD9 PCDH11X LHFPL2 RAD23B | 2.12e-05 | 413 | 119 | 11 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200 | 2.35e-05 | 61 | 119 | 5 | gudmap_developingGonad_e12.5_epididymis_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.23e-05 | 284 | 119 | 9 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | MGAM ASH1L SEMA5A PFKL KMT2E ECE1 PNISR CEMIP2 CRKL ZNF462 TENM4 STARD9 PCDH11X LHFPL2 RAD23B | 4.21e-05 | 801 | 119 | 15 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | ASAH2 SEMA5A WWTR1 ADAMTS5 ECE1 KLF4 CEMIP2 PXDN HOXD8 LHFPL2 CTNND1 | 4.63e-05 | 450 | 119 | 11 | GSM777063_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | MGAM ASH1L PFKL PNISR CEMIP2 ZNF462 TENM4 LHFPL2 STAG3 RAD23B | 9.18e-05 | 403 | 119 | 10 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | MGAM ASH1L NHLRC2 PFKL PNISR TENM4 PCDH11X LHFPL2 STAG3 RAD23B | 1.04e-04 | 409 | 119 | 10 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | MGAM ASH1L GJC1 SEMA5A PFKL KMT2E ECE1 PNISR ZNF462 TENM4 STARD9 PCDH11X LHFPL2 RAD23B | 1.38e-04 | 790 | 119 | 14 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.45e-04 | 89 | 119 | 5 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.50e-04 | 142 | 119 | 6 | gudmap_developingKidney_e15.5_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_200 | 1.61e-04 | 91 | 119 | 5 | gudmap_developingGonad_e14.5_ epididymis_200_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | CRTC3 RPS6KA3 DCBLD1 COL6A5 WWTR1 PLD3 KLF4 PPOX PCF11 SEMA6D LMO7 STARD9 PCDH11X NOS1 | 1.63e-04 | 803 | 119 | 14 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | MGAM ASH1L GJC1 PFKL KMT2E ECE1 PNISR CEMIP2 CRKL ZNF462 TENM4 LHFPL2 STAG3 RAD23B | 1.70e-04 | 806 | 119 | 14 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | ASAH2 WWTR1 PLXND1 ECE1 KLF4 CEMIP2 PXDN HOXD8 LHFPL2 CTNND1 | 1.84e-04 | 439 | 119 | 10 | GSM777059_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | MGAM ASH1L NHLRC2 PFKL KMT2E ECE1 PNISR CEMIP2 ZNF462 TENM4 PCDH11X ADAMTS18 LHFPL2 RAD23B | 1.90e-04 | 815 | 119 | 14 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.91e-04 | 51 | 119 | 4 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 2.02e-04 | 150 | 119 | 6 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 2.17e-04 | 152 | 119 | 6 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.80e-04 | 225 | 119 | 7 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 2.97e-04 | 161 | 119 | 6 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | 3.35e-04 | 387 | 119 | 9 | gudmap_developingGonad_e16.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 3.61e-04 | 167 | 119 | 6 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500 | 3.73e-04 | 109 | 119 | 5 | gudmap_developingGonad_e16.5_ovary_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | ARHGAP32 GALNT3 RPS6KA3 GATA3 DCBLD1 SEMA5A PNISR FAM171A1 HOXD8 TBC1D1 LRP2 LHFPL2 SUZ12 | 4.05e-04 | 774 | 119 | 13 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 4.22e-04 | 172 | 119 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 4.58e-04 | 404 | 119 | 9 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 4.75e-04 | 406 | 119 | 9 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | ATP8B4 ASH1L PFKL PLD3 KMT2E ECE1 PNISR TENM4 SEMA6D KLF1 LHFPL2 STAG3 RAD23B | 5.21e-04 | 795 | 119 | 13 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | MGAM ASH1L NHLRC2 PFKL KMT2E PNISR CEMIP2 TENM4 PCDH11X ADAMTS18 LHFPL2 STAG3 RAD23B | 5.78e-04 | 804 | 119 | 13 | gudmap_developingGonad_e12.5_ovary_1000 |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 2.35e-08 | 170 | 122 | 8 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.64e-07 | 180 | 122 | 7 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-07 | 184 | 122 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-07 | 184 | 122 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-07 | 184 | 122 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.20e-07 | 189 | 122 | 7 | d17e8467699c7ca7694a313c26111f085df5204e | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.88e-07 | 191 | 122 | 7 | fcdf3a747038e346a467eae8b7c293592658b53f | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 192 | 122 | 7 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 192 | 122 | 7 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 194 | 122 | 7 | c8b9551b93a5aed62154b487db90130604a6125c | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 1.13e-06 | 195 | 122 | 7 | 6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.21e-06 | 197 | 122 | 7 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.30e-06 | 199 | 122 | 7 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | distal-Endothelial-Vein-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.34e-06 | 200 | 122 | 7 | ff88d28162e0231d5dac0e0c6bec98fa8da58a23 | |
| ToppCell | distal-2-Endothelial-Vein|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.34e-06 | 200 | 122 | 7 | 2785225956d2422acab90e99b7debe3709cf3308 | |
| ToppCell | Dendritic_Cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.79e-06 | 151 | 122 | 6 | e089bf197ed60e7243160521d4390d4b40a3832b | |
| ToppCell | COPD-Lymphoid-ILC_A|COPD / Disease state, Lineage and Cell class | 9.13e-06 | 176 | 122 | 6 | 484452cb38fe4604f0910a068361ed461b5b0c21 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 179 | 122 | 6 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 1.04e-05 | 180 | 122 | 6 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.14e-05 | 183 | 122 | 6 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-Neutrophil|Influenza_Severe / Disease, condition lineage and cell class | 1.25e-05 | 186 | 122 | 6 | 1dfcec9196d4db76fba3abc74e85885b1fb98b87 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-05 | 186 | 122 | 6 | 2e024097ee361eeb1d855a4edb8ac8cdad35da06 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-05 | 186 | 122 | 6 | c3449e54454009973818fc1101933c6f0168258c | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 187 | 122 | 6 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 187 | 122 | 6 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.29e-05 | 187 | 122 | 6 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.33e-05 | 188 | 122 | 6 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | control-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.37e-05 | 189 | 122 | 6 | bdfd120900ba58d5e54765f7b576e1f8cc2401bf | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.37e-05 | 189 | 122 | 6 | 360f09f46231a83f99d8fa0158b72a38068e1642 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.37e-05 | 189 | 122 | 6 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.41e-05 | 190 | 122 | 6 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.41e-05 | 190 | 122 | 6 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.41e-05 | 190 | 122 | 6 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.45e-05 | 191 | 122 | 6 | d162917816dd2e4767c97447c1cddae9397713ab | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.50e-05 | 192 | 122 | 6 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-05 | 192 | 122 | 6 | cd4c9b9ab17a779c154264f7459020f51e528ba5 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 193 | 122 | 6 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 193 | 122 | 6 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-05 | 193 | 122 | 6 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-05 | 194 | 122 | 6 | f8a59bd4609d147d8a706bf606e9e8173c9992a3 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-05 | 194 | 122 | 6 | 04b1acc2e879feafb43f75435281c5acd8d23be2 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 194 | 122 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | droplet-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-05 | 195 | 122 | 6 | 0c15be3e7c238e329505dcbbe197a977d1019d45 | |
| ToppCell | control-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.63e-05 | 195 | 122 | 6 | 66959ae839eb60a573da06bdd227090ebb5bb9ed | |
| ToppCell | droplet-Lung-18m-Endothelial-venous_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-05 | 195 | 122 | 6 | 45ac0fdbeb0982d798c613a6d15715d725608aa9 | |
| ToppCell | droplet-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-05 | 195 | 122 | 6 | 5b1f04a745467876b09113ee17ababd3fcf9fb01 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.63e-05 | 195 | 122 | 6 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.68e-05 | 196 | 122 | 6 | 28e9e191361966df3a9bd48450090577aa72a999 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 197 | 122 | 6 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-05 | 197 | 122 | 6 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 197 | 122 | 6 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-05 | 197 | 122 | 6 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.73e-05 | 197 | 122 | 6 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-05 | 198 | 122 | 6 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.83e-05 | 199 | 122 | 6 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-05 | 200 | 122 | 6 | ea039de8bd8b325845ce361f84e600c6dad922ed | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.89e-05 | 200 | 122 | 6 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.89e-05 | 200 | 122 | 6 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.89e-05 | 200 | 122 | 6 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | medial-Endothelial-Vein-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.89e-05 | 200 | 122 | 6 | 3f689029f5bc7db0af50a405f1e252aeec529077 | |
| ToppCell | medial-Endothelial-Vein|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.89e-05 | 200 | 122 | 6 | 1163e5f6dfb304c94bf8885629350454f4b6bee8 | |
| ToppCell | medial-2-Endothelial-Vein|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.89e-05 | 200 | 122 | 6 | 49da4e3ff10262a492c2cf566a7f2e35e418bfda | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.09e-05 | 121 | 122 | 5 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.74e-05 | 128 | 122 | 5 | 58639cfdc70ff6764adcc5c1ce9eba9d033b8209 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.74e-05 | 128 | 122 | 5 | 9b3c57d559a5ed8d590dd89b64a57a3227d8c684 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-05 | 148 | 122 | 5 | b4632029ebd14969bda59a1bd1454eadb8efe563 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-05 | 148 | 122 | 5 | ba277c898678dd36f8dc1d681301c71901b89055 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.41e-05 | 153 | 122 | 5 | 4eb9c2d7e4b95d44198fc87dc115a08ef0153e26 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.41e-05 | 153 | 122 | 5 | 26b5b45c117d155b028d298a0b93e16d343dca97 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.41e-05 | 153 | 122 | 5 | 0f12e38f2cbf69a520764289b0aa4dedc645f714 | |
| ToppCell | Severe-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.41e-05 | 153 | 122 | 5 | 44572f87d403e314050ab935d2cd676c33d9c287 | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.24e-05 | 157 | 122 | 5 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.69e-05 | 159 | 122 | 5 | f7bccfeffa737f151417bf52ea45111b0957bce9 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-05 | 168 | 122 | 5 | 3bddf411a60137a8883fc9e77586e4719b0d6067 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-05 | 168 | 122 | 5 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-05 | 168 | 122 | 5 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.96e-05 | 168 | 122 | 5 | 27cdf5cfa1d906868cfd60fdfab3cd51f3b3602f | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-05 | 168 | 122 | 5 | b6d948857ee652351ddbe383b75fdd1721cd8721 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.02e-04 | 169 | 122 | 5 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 169 | 122 | 5 | f086b50791e1c93e253eb5e8d6c4bf617b1416c3 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-04 | 170 | 122 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.05e-04 | 170 | 122 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.08e-04 | 171 | 122 | 5 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-04 | 172 | 122 | 5 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.14e-04 | 173 | 122 | 5 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-04 | 173 | 122 | 5 | 4968712af1cca8c932abd3323631d7dcaffd4a66 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 173 | 122 | 5 | 9a04271c51fae34f547db3206f9ff5857686e45c | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-04 | 174 | 122 | 5 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-04 | 174 | 122 | 5 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-04 | 174 | 122 | 5 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 175 | 122 | 5 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 175 | 122 | 5 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | COPD-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 1.21e-04 | 175 | 122 | 5 | e773e330de36f8a0aa9398a176ed7edb5599c582 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-04 | 176 | 122 | 5 | 96779273b94345250cf53ba671203345b43d9e00 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-04 | 176 | 122 | 5 | 27e6b3ae41068d6cfdda3d46da7df2a27567140e | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-04 | 176 | 122 | 5 | d6a5470af9592f34a741265f2ea9651c05c3add3 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 177 | 122 | 5 | 6d86b2f97426b552dff5ce6ddf0ead1285ed618e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 177 | 122 | 5 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 177 | 122 | 5 | d8b1bbc224d062a57a6ad40b4b2af5d6e0fe63b3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-04 | 178 | 122 | 5 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| Drug | PNU-0251126 [267429-19-6]; Up 200; 1uM; PC3; HT_HG-U133A | TBXAS1 ATN1 SEMA5A ECE1 CRKL HIPK3 GRTP1 ZMIZ2 CNTNAP2 MYO15A | 9.07e-08 | 196 | 120 | 10 | 3692_UP |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 8.72e-07 | 193 | 120 | 9 | 5922_UP | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; PC3; HT_HG-U133A | 9.92e-07 | 196 | 120 | 9 | 6637_DN | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.96e-06 | 179 | 120 | 8 | 3630_UP | |
| Drug | STOCK1N-35215; Up 200; 10uM; PC3; HT_HG-U133A | 5.60e-06 | 182 | 120 | 8 | 6427_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 7.68e-06 | 190 | 120 | 8 | 4274_UP | |
| Drug | CP-645525-01 [287190-82-3]; Up 200; 10uM; PC3; HT_HG-U133A | 8.95e-06 | 194 | 120 | 8 | 7527_UP | |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | 9.29e-06 | 195 | 120 | 8 | 4199_DN | |
| Drug | Tocainide hydrochloride; Down 200; 17.4uM; PC3; HT_HG-U133A | 9.64e-06 | 196 | 120 | 8 | 4256_DN | |
| Drug | Glycopyrrolate [596-51-0]; Up 200; 10uM; PC3; HT_HG-U133A | 1.00e-05 | 197 | 120 | 8 | 3687_UP | |
| Drug | Amrinone [60719-84-8]; Up 200; 21.4uM; PC3; HT_HG-U133A | 1.00e-05 | 197 | 120 | 8 | 4488_UP | |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.00e-05 | 197 | 120 | 8 | 4684_DN | |
| Drug | 16, 16-dimethylprostaglandin E2 methyl acetate solution; Down 200; 10uM; PC3; HT_HG-U133A | 1.04e-05 | 198 | 120 | 8 | 6592_DN | |
| Drug | Imipenem [74431-23-5]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.04e-05 | 198 | 120 | 8 | 7294_UP | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.04e-05 | 198 | 120 | 8 | 7363_DN | |
| Drug | Ald1.1-H_000455; Down 200; 10uM; PC3; HT_HG-U133A | 1.08e-05 | 199 | 120 | 8 | 7547_DN | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; PC3; HT_HG-U133A | 1.12e-05 | 200 | 120 | 8 | 3682_DN | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 5.54e-05 | 184 | 120 | 7 | 4430_DN | |
| Drug | Withaferin A [5119-48-2]; Down 200; 1uM; PC3; HT_HG-U133A | 5.93e-05 | 186 | 120 | 7 | 3819_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; PC3; HT_HG-U133A | 7.48e-05 | 193 | 120 | 7 | 3708_UP | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 7.48e-05 | 193 | 120 | 7 | 5584_DN | |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 7.48e-05 | 193 | 120 | 7 | 5985_DN | |
| Drug | Halcinonide [3093-35-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 7.73e-05 | 194 | 120 | 7 | 3680_UP | |
| Drug | semustine; Down 200; 100uM; PC3; HT_HG-U133A | 7.73e-05 | 194 | 120 | 7 | 7545_DN | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; PC3; HT_HG-U133A | 7.73e-05 | 194 | 120 | 7 | 5091_UP | |
| Drug | radicicol; Down 200; 0.1uM; PC3; HT_HG-U133A | 7.73e-05 | 194 | 120 | 7 | 5952_DN | |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HG-U133A | 7.98e-05 | 195 | 120 | 7 | 489_DN | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 5702_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 6440_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 3714_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; HL60; HG-U133A | 7.98e-05 | 195 | 120 | 7 | 1981_DN | |
| Drug | Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; PC3; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 3669_UP | |
| Drug | Beta-sistosterol [83-46-5]; Down 200; 9.6uM; PC3; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 4073_DN | |
| Drug | Demecarium bromide [56-94-0]; Down 200; 5.6uM; HL60; HG-U133A | 8.24e-05 | 196 | 120 | 7 | 1781_DN | |
| Drug | probucol; Up 200; 10uM; MCF7; HG-U133A | 8.24e-05 | 196 | 120 | 7 | 592_UP | |
| Drug | Beta-sistosterol [83-46-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 8.24e-05 | 196 | 120 | 7 | 4154_UP | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; PC3; HT_HG-U133A | 8.24e-05 | 196 | 120 | 7 | 4683_DN | |
| Drug | Bretylium tosylate [61-75-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 8.24e-05 | 196 | 120 | 7 | 3394_UP | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; PC3; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 3801_DN | |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 1508_DN | |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; PC3; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 4674_DN | |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 6359_DN | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; PC3; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 6641_DN | |
| Drug | novobiocin sodium, USP; Up 200; 100uM; MCF7; HG-U133A | 8.78e-05 | 198 | 120 | 7 | 342_UP | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; PC3; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 3781_UP | |
| Drug | Harmane hydrochloride [21655-84-5]; Down 200; 18.2uM; PC3; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 4584_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; PC3; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 6611_UP | |
| Drug | Trimethadione [127-48-0]; Up 200; 28uM; HL60; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 2486_UP | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 4805_DN | |
| Drug | Protoveratrine A [143-57-7]; Up 200; 5uM; HL60; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 2144_UP | |
| Drug | Palmatine chloride [3486-67-7]; Up 200; 10.4uM; PC3; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 6612_UP | |
| Drug | rotenone; Down 200; 1uM; PC3; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 5920_DN | |
| Drug | DNA-PK Inhibitor III; Down 200; 1uM; PC3; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 7548_DN | |
| Drug | Nitrofurantoin [67-20-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 3674_UP | |
| Drug | Pentamidine isethionate [140-64-7]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 4396_UP | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 3543_DN | |
| Drug | Delsoline [509-18-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 9.35e-05 | 200 | 120 | 7 | 6075_UP | |
| Drug | glycidol | 1.83e-04 | 466 | 120 | 10 | ctd:C004312 | |
| Disease | interleukin 12 measurement | 6.32e-05 | 53 | 119 | 4 | EFO_0004753 | |
| Disease | Intellectual Disability | 8.62e-05 | 447 | 119 | 9 | C3714756 | |
| Disease | birth weight | 2.21e-04 | 399 | 119 | 8 | EFO_0004344 | |
| Disease | age at diagnosis, substance-related disorder | 2.39e-04 | 6 | 119 | 2 | EFO_0004918, MONDO_0002494 | |
| Disease | intellectual disability (is_implicated_in) | 2.40e-04 | 30 | 119 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | nose morphology measurement | 3.88e-04 | 329 | 119 | 7 | EFO_0007843 | |
| Disease | FEV/FEC ratio | MGAM ATP8B4 NEBL DCBLD1 WWTR1 ADAMTS5 CEMIP2 ZNF106 CTAGE1 CNTNAP2 LHFPL2 SUZ12 MYO15A RAD23B | 4.38e-04 | 1228 | 119 | 14 | EFO_0004713 |
| Disease | inflammatory bowel disease | 4.86e-04 | 449 | 119 | 8 | EFO_0003767 | |
| Disease | Colorectal Carcinoma | RBM10 PPOX CDKL5 SPACA7 BCL11B LMO7 PCDH11X LRP2 ADAMTS18 PIGO | 5.66e-04 | 702 | 119 | 10 | C0009402 |
| Disease | virologic response measurement, response to abacavir | 6.55e-04 | 42 | 119 | 3 | EFO_0006905, EFO_0006906 | |
| Disease | creatinine measurement | ADGRV1 KLF4 SBNO2 CDKL5 COL18A1 DLGAP3 GRTP1 LRIG1 LRP2 ZNF396 CTNND1 BSN | 7.03e-04 | 995 | 119 | 12 | EFO_0004518 |
| Disease | acute necrotizing pancreatitis (implicated_via_orthology) | 7.11e-04 | 10 | 119 | 2 | DOID:0080998 (implicated_via_orthology) | |
| Disease | lactose measurement | 7.11e-04 | 10 | 119 | 2 | EFO_0010507 | |
| Disease | response to carboplatin, response to antineoplastic agent | 7.11e-04 | 10 | 119 | 2 | GO_0097327, GO_0097328 | |
| Disease | colorectal cancer | 7.82e-04 | 604 | 119 | 9 | MONDO_0005575 | |
| Disease | response to radiation, breast carcinoma | 8.66e-04 | 11 | 119 | 2 | EFO_0000305, GO_0009314 | |
| Disease | visual epilepsy (is_implicated_in) | 8.66e-04 | 11 | 119 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | Hodgkin lymphoma, lymphocyte depletion | 1.22e-03 | 13 | 119 | 2 | C0152267 | |
| Disease | Mixed Cellularity Hodgkin Lymphoma | 1.22e-03 | 13 | 119 | 2 | C0152266 | |
| Disease | Lymphocyte Rich Classical Hodgkin Lymphoma | 1.22e-03 | 13 | 119 | 2 | C1266194 | |
| Disease | Adult Hodgkin Lymphoma | 1.22e-03 | 13 | 119 | 2 | C0220597 | |
| Disease | Nodular Lymphocyte Predominant Hodgkin Lymphoma | 1.22e-03 | 13 | 119 | 2 | C1334968 | |
| Disease | household income | 1.49e-03 | 304 | 119 | 6 | EFO_0009695 | |
| Disease | glycerol-3-phosphate measurement | 1.64e-03 | 15 | 119 | 2 | EFO_0010488 | |
| Disease | hypertension (implicated_via_orthology) | 1.83e-03 | 128 | 119 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | smoking cessation | 2.09e-03 | 325 | 119 | 6 | EFO_0004319 | |
| Disease | Global developmental delay | 2.10e-03 | 133 | 119 | 4 | C0557874 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.13e-03 | 566 | 119 | 8 | EFO_0007660, EFO_0008354 | |
| Disease | sleep measurement | 2.22e-03 | 135 | 119 | 4 | EFO_0004870 | |
| Disease | lymphocyte count | FLNB GATA3 NHLRC2 PLXND1 PLD3 SBNO2 HOXA6 ZNF469 BCL11B TENM4 TBC1D1 NLRC5 CPNE1 HELZ | 2.34e-03 | 1464 | 119 | 14 | EFO_0004587 |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 2.37e-03 | 18 | 119 | 2 | HP_0002373 | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 2.64e-03 | 19 | 119 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | leukemia (implicated_via_orthology) | 2.64e-03 | 19 | 119 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | hemorrhoid | 3.01e-03 | 147 | 119 | 4 | EFO_0009552 | |
| Disease | cortical surface area measurement | ATXN2L FLNB ABI1 SEMA5A PLXND1 ADGRV1 CRKL ZNF106 ZNF469 BCL11B LRIG1 ADAMTS18 RAD23B | 3.06e-03 | 1345 | 119 | 13 | EFO_0010736 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.40e-03 | 152 | 119 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement | TRERF1 ATXN2L ZSWIM8 BAAT ZNF106 ZNF469 PXDN GRTP1 MROH6 TBC1D1 ZMIZ2 BSN | 3.51e-03 | 1206 | 119 | 12 | EFO_0004458 |
| Disease | Hodgkin Disease | 3.53e-03 | 22 | 119 | 2 | C0019829 | |
| Disease | neuroimaging measurement | ATXN2L CELF4 GJC1 PLXND1 ZNF462 COL18A1 ZNF106 ZNF469 BCL11B ADAMTS18 RAD23B | 4.02e-03 | 1069 | 119 | 11 | EFO_0004346 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NFPFGIPQVYHGQIH | 261 | Q14032 | |
| PHYVPDNYKRNGGRS | 2826 | Q9NR48 | |
| PYGLDVPNTAFGRQH | 471 | Q96RT6 | |
| GVQFAYRHCNNPAPR | 586 | Q9UNA0 | |
| SPGNRNHPFYVPLGA | 896 | P54259 | |
| AFGTVNPKYHPSRNN | 1336 | Q8WXG9 | |
| AQFSAQPHVNGGPLY | 341 | Q8IZP0 | |
| QPHVNGGPLYSQNSI | 346 | Q8IZP0 | |
| GIFPNQFPFVGNARH | 1046 | Q8TF62 | |
| FQERHCNNPKPQYGG | 611 | Q8TE60 | |
| SGQPQQNLYHPGALT | 906 | Q8WWM7 | |
| INNGSYIAAFPPHEG | 331 | Q9BYT9 | |
| SGGHPLEFLRNQPQF | 271 | P54727 | |
| FSRAQPGAAPGIYQQ | 496 | P98175 | |
| QQHPQAAASYRGQPG | 531 | Q96PK6 | |
| QPGFAFGVQQLHPAL | 96 | Q9BX46 | |
| PHQAQLGQLSYLAPG | 346 | Q86UR1 | |
| EYGDLHLFGPNQRPA | 61 | Q8IV08 | |
| QLFLPHGQPFYAAFG | 751 | Q9BQK8 | |
| HGQPFYAAFGNRPND | 756 | Q9BQK8 | |
| HADSPAPVNGINGYN | 686 | Q14566 | |
| SGFQGARPQPRVHFQ | 136 | Q5VUB5 | |
| PPLHYQGQSRGFVAR | 361 | O43474 | |
| FGYSPGQQQTHPQGS | 101 | Q8TAP9 | |
| AARYHLVQQLFPGPG | 106 | Q9NPI8 | |
| QRGPGDYLHFSPEQQ | 96 | P31267 | |
| YSRGQAFHPQPVSRD | 941 | Q96JA1 | |
| LQLYGNSAAGFPHAP | 51 | P13378 | |
| VQQYNGRALGENPPH | 1276 | Q9UKN7 | |
| YVFSQPGALSGPINH | 266 | Q8IUS5 | |
| PGALSGPINHYRNIF | 271 | Q8IUS5 | |
| AGFYHPGVLPVNNFR | 356 | Q5T848 | |
| GIPPSANAHQLFRGF | 371 | P51812 | |
| PESPLFQNFSGYHIG | 91 | Q9NR71 | |
| LGAFYPFSRNHNGQG | 676 | O43451 | |
| LPNQQAFRPTGHYAG | 3106 | Q9UPA5 | |
| NIPHSPYRVNIGQGS | 726 | O75369 | |
| PAGQLPSRFHQYQQH | 106 | Q12796 | |
| GPAFGHQIAYCNLLP | 651 | Q9Y4D7 | |
| LQQGGAPTPFDRNYG | 661 | P17858 | |
| GPDANSGQVARYHFP | 486 | P39060 | |
| RAQVPPTFQNNYHGS | 1841 | Q8IZD2 | |
| LGRKAQSNPYYNGPH | 176 | Q8WWI1 | |
| PGVQHFQRDTLCGPY | 71 | Q6ZUX7 | |
| QLHSRGFQALFPVGP | 171 | O75022 | |
| NNPRSVVVHPFAGYL | 826 | P98164 | |
| RYPGHVPNFLSQTQG | 591 | A6NGR9 | |
| NFYVPENLPRHGTVG | 576 | Q9BZA7 | |
| GNRNSNSYGIPEPAH | 191 | P46109 | |
| PRANVTGYFSPNDHN | 1711 | A7KAX9 | |
| ANLQQNHLMGPGFPY | 1686 | P42694 | |
| PRTYVNGRNFGNSHP | 41 | Q9H422 | |
| NAYPHKAGFAQPSGL | 401 | Q8NBF2 | |
| QGRHNPPDDIGSSFY | 141 | Q5SRI9 | |
| QQRYRSQIPGSGQPH | 156 | Q86WI3 | |
| AGRQPDSPTALYHFN | 911 | Q9BQG0 | |
| QYQPGDHLGVFPGNH | 1031 | P29475 | |
| HGPGNQSFSNPLNRA | 1171 | O94913 | |
| AYFNGSLPPQTVGHQ | 406 | Q8IZD4 | |
| QGNHVPPYYGNSVRA | 56 | P23771 | |
| FPAGILQAPFYARNH | 691 | P0DPD8 | |
| QYQGHFQLFRGLQGP | 211 | Q13351 | |
| QNTHGFRIYLEPGPA | 241 | Q9C0K0 | |
| FHPLPFQNAGAQGRG | 766 | Q9BX69 | |
| FGHNAPPAAPTSRNY | 421 | Q96PV7 | |
| AFPHNGQNLGLSPFL | 251 | Q6UUV7 | |
| LAVQAYSHQNNPHGP | 351 | P36383 | |
| FNKPSPYGSNHNRGN | 316 | Q14435 | |
| ALAEINPNHPFQGQY | 556 | Q8NBF6 | |
| QGQPLFQGHPQLESY | 1206 | A8TX70 | |
| NPGYYHQLLQGERNP | 91 | Q5TC63 | |
| VQQDGFHTLPYQRGP | 131 | O95886 | |
| YHEPQPGVYNFNGSR | 86 | Q6UWU2 | |
| SRGHSPAFLQPQNGN | 6 | Q9UHN6 | |
| GQFHVYQENAPGLPV | 136 | P40198 | |
| HPYFQVGQVLGPSSN | 281 | P20794 | |
| LGCTFVQNHFRPPGQ | 516 | Q9UH90 | |
| NPSGIVLHPAGYQNV | 211 | Q9BPY3 | |
| SLGGLQQPGPHNFYS | 226 | Q8IXV7 | |
| ADFPYNPGQGQAIRN | 1241 | Q9UHC6 | |
| YPNGLQVNFHSPRSG | 41 | P42892 | |
| GAQDGDYQRPHSAQP | 646 | Q8N8Z6 | |
| GAKSGPNGHPYNRTN | 931 | O76039 | |
| QAGTATLPRNFHYPP | 196 | O60716 | |
| YGPTNFAPIINHVAR | 386 | Q99829 | |
| GAGLQSHLYQPAFPG | 261 | Q5XKR4 | |
| TAFGHPQAYQGPATG | 146 | Q9Y5X1 | |
| HGVSPVNAFPAQNNY | 211 | Q8NBJ7 | |
| NANLHGDPSENYRGP | 121 | Q96KW9 | |
| PNNSLLSGYPHVAGF | 66 | A6NJ46 | |
| NPGTFRLQGQPGYFN | 66 | A0A1B0GUY1 | |
| FLAPGHPQDGQVVFY | 1026 | Q9Y2G9 | |
| PQPAAQRSGHLYTGR | 3281 | Q9P2P6 | |
| PNPHFQCGTVDQGLY | 351 | Q13591 | |
| QPAAEAVFANGIHPY | 351 | Q9BZC1 | |
| HPAAQNRFLYVGGAL | 91 | P50336 | |
| RQQHRPFTYLPFGAG | 461 | P24557 | |
| QPHSGQDFAYGSRPQ | 61 | Q9UPR6 | |
| LGYPNGHFSQEIFTP | 131 | Q8NA42 | |
| RSRFLGPQYFQTPHN | 1146 | Q9UJ98 | |
| SGLCYVQNHFGPNPT | 301 | Q6NTF9 | |
| GLRQSQHPYSVAPAG | 1116 | Q6ZMY3 | |
| DGSYAGNPQDIHRQP | 496 | Q15022 | |
| FPTHPYFSAQLGAGQ | 856 | Q86TI0 | |
| YENGFNTPRGINPHR | 771 | Q92626 | |
| NTPRGINPHRLYNGH | 776 | Q92626 | |
| LTFGFQLHNVIPGYP | 2476 | Q6N022 | |
| GQRIYNFAHRFPPAS | 106 | Q8TCE9 | |
| FNSQFLQHGGPRGPS | 191 | Q8NF64 | |
| LPQRHFPGQAYRASG | 401 | Q96JG9 | |
| SAYPQGVHPAFLGAQ | 1546 | A7E2V4 | |
| QPYQPNFEFVGGLHC | 266 | Q6UWM9 | |
| GYYGQHIAANPKPTN | 91 | Q96JM2 | |
| TNPPRHNGAYALRLG | 611 | Q8TEQ8 | |
| VNQFDYQHGAAFGPP | 161 | Q8TF01 | |
| GSYPFQALRQRSHGG | 516 | Q8NHP8 | |
| NHPLYTPPSFGNRQI | 236 | Q5HYJ1 | |
| RQFGYQDSPGPHEAL | 56 | Q96N95 | |
| YPVFRGRPSGNESQH | 41 | Q8NFY4 | |
| NYSGPGDKFQPGRNR | 236 | Q9H2Y7 | |
| SDPFLNGGPYHSREQ | 296 | Q9GZV5 | |
| YQQPPLGVHSGLNHN | 21 | Q96PN7 | |
| GFLNPRLYQQHGAGL | 501 | O14773 | |
| NYHLNIQRFSGPPNP | 286 | Q92802 | |
| GRSHTPSPNDYRNFN | 181 | Q8TDC0 | |
| APVLPGAYQQSHSQG | 921 | O76041 |